These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3265277)

  • 1. Biological modification of lipoproteins and its role in atherogenesis.
    Carew TE; Parthasarathy S
    Agents Actions Suppl; 1988; 26():191-200. PubMed ID: 3265277
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis.
    Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Arai H; Kawai C
    Eur Heart J; 1990 Aug; 11 Suppl E():122-7. PubMed ID: 2226520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild oxidation of lipoproteins increases their affinity for surfaces covered by heparan sulfate and lipoprotein lipase.
    Makoveichuk E; Lookene A; Olivecrona G
    Biochem Biophys Res Commun; 1998 Nov; 252(3):703-10. PubMed ID: 9837770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoproteins, cholesterol ester transport and atherogenesis.
    Eisenberg S
    Monogr Atheroscler; 1986; 14():107-12. PubMed ID: 3736547
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cellular and extracellular lipid binding].
    Kopieczna-Grzebieniak E; Piskorska D
    Przegl Lek; 1988; 45(7):588-91. PubMed ID: 3070640
    [No Abstract]   [Full Text] [Related]  

  • 6. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations.
    Bradley WA; Gianturco SH
    J Intern Med Suppl; 1994; 736():33-9. PubMed ID: 7986306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of biologically modified low-density lipoprotein in atherosclerosis.
    Carew TE
    Am J Cardiol; 1989 Oct; 64(13):18G-22G. PubMed ID: 2679026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxidized lipoproteins and atherogenesis].
    Bellomo G; Maggi E; Palladini G; Seccia M; Perani G; Marchesi E; Finardi G
    Cardiologia; 1996 May; 41(5):417-25. PubMed ID: 8767630
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.
    Fruebis J; Steinberg D; Dresel HA; Carew TE
    J Clin Invest; 1994 Jul; 94(1):392-8. PubMed ID: 8040279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.
    McPherson PA; Young IS; McEneny J
    Free Radic Biol Med; 2007 Dec; 43(11):1484-93. PubMed ID: 17964419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure, metabolism, functions and plasma changes in high density lipoproteins (HDL)].
    Dewailly P; Sezille G; Jaillard J
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():65-81. PubMed ID: 6995678
    [No Abstract]   [Full Text] [Related]  

  • 13. [Structure and metabolism of lipoproteins].
    Beucler I; Salmon S; Petit E; Ayrault-Jarrier M; Polonovski J
    Ann Biol Clin (Paris); 1986; 44(5):531-5. PubMed ID: 3544976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein metabolism in arterial walls and its relationship with the genesis of atheromatous lesion].
    Gaeta G; Effuso L; Maurea N; Boccalatte M; Scala R; Sifola C; Antignano A
    Clin Ter; 1994 Jan; 144(1):63-72. PubMed ID: 8168354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoproteins and atherosclerosis.
    Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Otani H; Arai H; Ueda Y; Kawai C
    Jpn Circ J; 1990 Sep; 54(9):1226-32. PubMed ID: 2176246
    [No Abstract]   [Full Text] [Related]  

  • 16. [Structure and metabolism of plasma lipoproteins].
    Polonovski J; Beucler I
    Pathol Biol (Paris); 1983 Apr; 31(4):225-34. PubMed ID: 6346237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Processes of modification of lipoproteins. Physiological and pathogenetical role of modified lipoproteins].
    Belova LA; Ogloblina OG; Belov AA; Kukharchuk VV
    Vopr Med Khim; 2000; 46(1):8-21. PubMed ID: 10802881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoproteins and arteriosclerosis].
    Ras Monleón RM
    Med Clin (Barc); 1985 Nov; 85(16):664-6. PubMed ID: 4079562
    [No Abstract]   [Full Text] [Related]  

  • 19. Cigarette smoke and lipoprotein modification. A possible interpretation for development of atherosclerosis.
    Yokode M; Nagano Y; Arai H; Ueyama K; Ueda Y; Kita T
    Ann N Y Acad Sci; 1995 Jan; 748():294-300. PubMed ID: 7695173
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-density lipoprotein (LDL) receptors and the regulation of serum LDL levels.
    Vermeer BJ
    Neth J Med; 1985; 28(2):52-8. PubMed ID: 3919323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.